| Thanh Dinh Trinh, DMD | |
|
217 Hollyhill Dr, Bakersfield, CA 93312-7062 | |
| (661) 872-6082 | |
| Not Available |
| Full Name | Thanh Dinh Trinh |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 217 Hollyhill Dr, Bakersfield, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497922603 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | D47197 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Thanh Dinh Trinh, DMD 217 Hollyhill Dr, Bakersfield, CA 93312-7062 Ph: (661) 872-6082 | Thanh Dinh Trinh, DMD 217 Hollyhill Dr, Bakersfield, CA 93312-7062 Ph: (661) 872-6082 |
News Archive
An assistant professor with the Virginia Tech - Wake Forest School of Biomedical Engineering has developed a flexible microneedle patch that allows drugs to be delivered directly and fully through the skin. The new patch can quicken drug delivery time while cutting waste, and can likely minimize side-effects in some cases, notable in vaccinations and cancer therapy.
Scientists have identified a key molecular player in a chain of events in the body that can lead to fatty liver disease, Type II diabetes and other metabolic abnormalities associated with obesity. By blocking this molecule, the researchers were able to reverse some of the pathology it caused in obese mice.
Chemists have long sought to develop new reactions for the direct conversion of simple hydrocarbon building blocks into valuable materials such as pharmaceuticals in a way that dependably creates the same chemical bonds and orientations.
President Obama unveiled a $3.8 trillion FY 2014 budget request on Wednesday, Agence France-Presse/GlobalPost reports (4/10).
AVANIR Pharmaceuticals, Inc. today announced the presentation of detailed data, including safety and tolerability data from the open-label extension as well as cardiac safety data from the double-blind phase of the Phase III confirmatory STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of pseudobulbar affect (PBA). The data were presented in two posters at the American Academy of Neurology (AAN) Annual Meeting in Toronto, Canada.
› Verified 2 days ago
Sarah Kim, Dentist Medicare: Not Enrolled in Medicare Practice Location: 3990 Ming Ave, Bakersfield, CA 93309 Phone: 661-323-1111 | |
Wasfi Fouad Salama, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1830 28th St, Bakersfield, CA 93301 Phone: 661-326-8536 Fax: 661-326-8511 | |
Dr. Rafaela Pauletto Szpoganicz, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 3615 Stockdale Hwy, Suite 2, Bakersfield, CA 93309 Phone: 661-456-0111 Fax: 661-829-4329 | |
Kathleen Marie Ihlendorf Rolfes, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1405 Commercial Way Ste 140, Bakersfield, CA 93309 Phone: 661-404-4063 | |
Dr. Jessica Anne Mahlmann, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3401 Coffee Rd, Bakersfield, CA 93308 Phone: 661-695-3044 | |
Dr. Michel Issa, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4221 S H St, Bakersfield, CA 93304 Phone: 661-200-0983 | |
Charles L Edwards, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 5509 Young St, Bakersfield, CA 93311 Phone: 661-664-6104 |